NFKB1 and Alzheimer disease: It was also reported that peptoids can be specifically designed to mimic the hydrophobic core of Aβ in AD and incorporate a neutral, positive, or negative spacer between aromatic side chains, which can abate Aβ aggregation and reduce the aggregate-induced NF-κB activation in neuronal cells [86].